Marijuana stocks to watch: MedMen’s vision becomes reality with largest-ever U.S. pot merger
October 17, 2018 at 12:12 PM EDT
MedMen Enterprises co-founder Adam Bierman believes the company’s $682 million acquisition of PharmCann last week marks the culmination of the U.S. cannabis industry’s transformation from vision to reality.
